… Melanoma treatment has significantly evolved due to extensive research and the introduction of novel therapeutic options. Dr. Justin T.…
Browsing: Melanoma and Skin
What is the new treatment for metastatic melanoma? On February 16, 2024, the medical community witnessed a significant milestone in…
By. Katy Tsai, MDDate: 11/21/2023Katy Tsai, MD, discusses the progress in cancer survivorship on a national scale, citing data from…
By: Allison Betof Warner, MD, PhD, StanfordDate: 11/13/2023 From: MOASCImmuno-Oncology Determining Optimal Treatment Duration Transcript: The question of how long…
By. Mohammed Dar, MDDate. November 02, 2023Mohammed Dar, MD, observed significant advancements in the treatment of metastatic uveal melanoma, particularly…
By. Neil Gross, MDDate. October 26, 2023 In a discussion detailing the primary outcomes of the Phase 2 trial for…
KEYNOTE-716 trial brings to light the impressive efficacy of pembrolizumab as an adjuvant therapy for stage IIB or IIC melanoma.…
Omid Hamid, MD – The Angeles Clinic This phase 1/2 study evaluated the combination therapy of retifanlimab, INCAGN02385 (Anti–LAG-3), and…
Jason Luke, MD, FACP, a renowned medical professional affiliated with the University of Pittsburgh Medical Center (UPMC), recently conducted a…
Omid Hamid, MD from The Angeles Clinic & Research Institute reports on the best Cutaneous Treatments from ASCO 2023 and…
IDE196 Solid Tumors GNAQ/11 Mutations or PRKC Fusions [2022] What is IDE196? And How Will It Help Patients With Solid…
SWOG S1801 Trial: Pembro After or Before Surgery? [2022] It is not yet known which type of immunotherapy, adjuvant or…
M14TIL Trial: TIL Compared to Std. Ipilimumab [2022] This is the first experiment to use tumor-infiltrating lymphocytes (TIL) in metastatic…
Shahid Gilani, MD from the University Hospital Of North Midlands speaks about Hypofractionated radiotherapy as a definitive treatment for Basal…
Question and Answer Session Justin Moyers, MD – ASCO 2022 Melanoma Overview: MOASC Spotlight https://oncologytube.com/v/41283 Justin Moyers, MD Exit Interview…
ASCO 2022 Melanoma (American Society of Clinical Oncology) In-Depth Slides: MOASC Spotlight on Oncology I’ll do a brief reminder of…
ASCO 2022 Melanoma Overview: MOASC Spotlight  KEYNOTE-716 Study  Today, we talked about some of the exciting new discoveries…
Audio: The FDA approval of multiple drugs um for the treatment of metastatic unresectable melanoma led to uh the concept…
T-Vec: + Pembro Advanced Melanoma MASTERKEY-115 Trial Dr Gastman By Brian Gastman, MD The FDA’s approval of multiple drugs for…
Transcript: The FDA approval of multiple drugs for the treatment of metastatic unresectable melanoma led to the concept that we…
Transcript – KEYNOTE-716 New Facts You Need To Know – Article Question – Please Tell Us About The KEYNOTE-716 Study.…
Professor Georgina V. Long, MD, PhD, FRACP, Chair of Melanoma Medical Oncology &Translational Research, Translational Node, Faculty of Medicine and…
Professor Georgina V. Long, MD, PhD, FRACP, Chair of Melanoma Medical Oncology &Translational Research, Translational Node, Faculty of Medicine and…
Jonathan Zager, MD, Chief Academic Officer, Chair, USF Department of Oncologic Sciences at Moffitt Cancer Center. In this audio, he…
Jonathan Zager, MD, Chief Academic Officer, Chair, USF Department of Oncologic Sciences at Moffitt Cancer Center. In this video, he…
Mansi Saxena, Ph.D., Associate Facility Director, Vaccine and Cell Therapy Laboratory at Icahn School of Medicine at Mount Sinai. In…
Mansi Saxena, Ph.D., Associate Facility Director, Vaccine and Cell Therapy Laboratory at Icahn School of Medicine at Mount Sinai. In…
Orphan Drug Designation Update: IDEAYA Biosciences inc Darovasertib and Crizotinib Synthetic Lethal Combination Expansion Dose in Heavily Pre-Treated Metastatic Uveal…
Meredith McKean, MD, Sarah Cannon Research Institute at Tennessee Oncology, Associate Director, Melanoma and Skin Cancer Research speaks about IDEAYA…
Jason Luke, MD, FACP, Director, Cancer Immunotherapeutics Center at UPMC Hillman Cancer Center speaks about FDA Approves Merck’s KEYTRUDA® (pembrolizumab)…
Jason Luke, MD, FACP, Director, Cancer Immunotherapeutics Center at UPMC Hillman Cancer Center speaks about FDA Approves Merck’s KEYTRUDA® (pembrolizumab)…
Philip O. Scumpia, MD, Ph.D. and Professor Aydogan Ozcan, Ph.D. from UCLA Health and UCLA Samueli Electrical & Computer Engineering…
Philip O. Scumpia, MD, Ph.D. and Professor Aydogan Ozcan, Ph.D. from UCLA Health and UCLA Samueli Electrical & Computer Engineering…
Todd William Ridky, M.D., Ph.D., Physician Scientist, Associate Professor of Dermatology at the Pearlman School of Medicine, University of Pennsylvania…
Todd William Ridky, M.D., Ph.D., Physician Scientist, Associate Professor of Dermatology at the Pearlman School of Medicine, University of Pennsylvania…
Meredith McKean, MD, Associate Director, Melanoma and Skin Cancer Research Program at Sarah Cannon Research Institute speaks about ESMO 2021…
Meredith McKean, MD, Associate Director, Melanoma and Skin Cancer Research Program at Sarah Cannon Research Institute speaks about ESMO 2021…
Prof. Dr. med. Dirk Schadendorf, Universitätsklinikum Essen speaks about the ESMO 2021 Abstract – 1091TiP – STARBOARD: Randomized phase III…
Prof. Dr. med. Dirk Schadendorf, Universitätsklinikum Essen speaks about the ESMO 2021 Abstract – 1091TiP – STARBOARD: Randomized phase III…
Joleen M. Hubbard, MD, Oncology Department, Mayo Clinic speaks about the ESMO 2021 Abstract – 507TiP – PRESERVE 1: A…
Jason J. Luke, MD, FACP, Cancer Immunotherapeutics Center, UPMC Hillman Cancer Center speaks about ESMO 2021 Abstract #LBA3, Presidential Symposium:…
Jason J. Luke, MD, FACP, Cancer Immunotherapeutics Center, UPMC Hillman Cancer Center speaks about ESMO 2021 Abstract #LBA3, Presidential Symposium:…
LluÃs Espinosa, MD from IMIM-Hospital del Mar and CIBERONC speaks about Optimising Metastatic Melanoma Therapy By Combining Two Treatments.Link to…
Sajeve Thomas, MD, an oncologist and hematologist at the Orlando Health Cancer Institute speaks about Using A Patient’s Own Tumor…
Sajeve Thomas, MD, an oncologist and hematologist at the Orlando Health Cancer Institute speaks about Using A Patient’s Own Tumor…
LluÃs Espinosa, MD from IMIM-Hospital del Mar and CIBERONC speaks about Optimising Metastatic Melanoma Therapy By Combining Two Treatments.Link to…
Jonathan Zager, MD from H. Lee Moffitt Cancer Center & Research Institute speaks about ASCO 2021 Abstract – Percutaneous hepatic…
Jonathan Strosberg, MD from H. Lee Moffitt Cancer Center & Research Institute speaks about the ASCO 2021 Abstract – Final…
Ana Maria Arance, MD from the Hospital Clinic Barcelona speaks about ASCO 2021 Abstract – Lenvatinib (len) plus pembrolizumab (pembro)…
Pauline Funchain, MD, Medical Oncologist/Cancer Genomics at Cleveland Clinic speaks about the ASCO 2021 Abstract – Final analysis of overall…